Skip to main content
. 2015 May 11;20(6):653–659. doi: 10.1634/theoncologist.2015-0008

Figure 1.

Figure 1.

Endpoint used to determine RP2D. Cumulative measure because multiple endpoints could be used for one agent. The total number of endpoints used for all 23 agents was 35.

Abbreviations: PD, pharmacodynamic; PK, pharmacokinetic; RP2D, recommended phase 2 dose.